Clinical Trial Update: Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed plus cisplatin as first-line therapy for stage IV or recurrent gastric cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-08-10